Showing 2421-2430 of 8591 results for "".
Chronic Hand Eczema Treatment Landscape
https://practicaldermatology.com/series/c-suite-chats/chronic-hand-eczema-treatment-landscape/29126/Jacob Thyssen, MD, PhD, Chief Scientific Officer at Leo Pharma, talks about the incidence of chronic hand eczema and the advantage that delgocitinib provides compared to other treatment options.PDT vs Topical Therapies for Pre-Cancerous Areas
https://practicaldermatology.com/series/pdt-in-practice/pdt-vs-topical-therapies-pre-cancerous-areas/26992/Dr. Hamza D. Bhatti, a board-certified dermatologist and dually accredited fellowship-trained Mohs micrographic surgeon and cosmetic dermatologic surgeon, discusses the advantages that photodynamic therapy (PDT) offers in terms of downtime and ease of compliance.How to Combine Injectables with Light- and Energy-Based Devices
https://practicaldermatology.com/conferences/maui-derm-2024/how-to-combine-injectables-with-light-and-energy-based-devices/20238/Beverly Hills cosmetic dermatologist Ava Shamban, MD, shares her expertise on using hyaluronic acid on the lateral side of the face to help fight “filler fatigue” in patients. “You can see it in the before and afters because of that glide plane lateral to the line of ligaments.”What's New in Topical Treatment for Plaque Psoriasis?
https://practicaldermatology.com/conferences/maui-derm-2024/whats-new-in-topical-treatment-for-plaque-psoriasis/20235/Linda Stein Gold, MD, director of dermatology clinical research at Henry Ford Health, discusses what’s new in topical treatment of plaque psoriasis and the importance of an “elegant vehicle” for patients to use in their care regimens.Top 2023 Psoriasis Treatment Announcements
https://practicaldermatology.com/topics/psoriasis/top-2023-psoriasis-treatment-announcements/20232/Daniel Schlessinger, MD, Mohs Micrographic Surgery and Cosmetic Dermatology Fellow at Northwestern University, reviews for Practical Dermatology® some of the important psoriasis drug approval news of 2023.Dermatology Innovations
https://practicaldermatology.com/topics/psoriasis/dermatology-innovations/20044/From topical therapies to JAK inhibitors, there are many new drugs available to treat a wide variety of dermatologic conditions. Neal Bhatia, MD reviews what's new for atopic dermatitis, alopecia areata, scabies, lice, onychomycosis, and more. Plus, he discusses the importance of new delivery systemAtopic Dermatitis in the Spotlight: Uncovering the Burden Beneath the Skin?
https://practicaldermatology.com/topics/atopic-dermatitis/atopic-dermatitis-in-the-spotlight-uncovering-the-burden-beneath-the-skin/20030/Highlighting the common symptoms experienced by patients and their perceived burden (including itch, lesions, pain and sleep disturbance), the impact of symptoms and particularly sleep disturbance on quality of life, activity, and mental health and the different atopic dermatitis phenotypes and relaAll Dressed Up: Optimal Wound Control to Reduce Scars
https://practicaldermatology.com/topics/skin-cancer-photoprotection/all-dressed-up-optimal-wound-control-to-reduce-scars/20022/Performing more than 25 million surgical procedures each year, dermatologists have the potential to create innumerable scars. Mara Weinstein Velez, MD talks about the best dressings to use to reduce the risk of scars and offers a look at laser-assisted drug delivery to address existing scars.Five easy ways to increase your clickthrough rate
https://practicaldermatology.com/topics/practice-management/five-easy-ways-to-increase-your-clickthrough-rate/19956/Your dermatology website’s placement on the Google search results page is important – but it is not everything. Check out this short video from Ekwa Marketing to discover a few simple ways to improve traffic, no matter where your link is on the search page.DermWireTV: 2020 in Review
https://practicaldermatology.com/topics/psoriasis/dermwiretv-2020-in-review/19882/Crisaborole ointment became the first and only steroid-free, topical prescription medication for mild to moderate AD in patients as young as three months of age. Ustekinumab is approved for pediatric patients with moderate to severe plaque psoriasis. FDA approved ixekizumab injection, 80mg/mL for t